Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once‐daily atorvastatin

Abstract

A supportive pharmaceutical care program consisting of review by patient and pharmacist of each patient's electronically compiled dosing history, plus educational reminders, improves patient adherence to the once-daily atorvastatin dosing regimen, mainly by extending persistence.